Tapewire

Nasdaq · USD

PBYI

PUMA BIOTECHNOLOGY, INC.

Export transactions ↓
Tapewire entity
5478
SEC CIK
0001401667
Parsed reports
383

Last 12 months

Inside the activity.

0 purchase rows · 17 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202606
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202605
Jul 202603
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 11, 2025 Filed Jun 14, 2025 00:14 UTC GrantCommon Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-020360 · rdgdoc.xml · nonDerivative · entry 1

Dorval Allison · CIK 0001625110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,000

F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 11, 2025 Filed Jun 14, 2025 00:10 UTC GrantCommon Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-020357 · rdgdoc.xml · nonDerivative · entry 1

Cesano Alessandra · CIK 0001827015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,000

F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 18:55 UTC
Ludwig Jeffrey JeromeChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 66,221 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001437749-25-003459 · rdgdoc.xml · derivative · entry 2

Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,221

Underlying: Common Stock · 66,221 shares

Expires 2035-02-06

F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Optionee's continued service with the Company through the applicable vesting date.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 18:55 UTC
Ludwig Jeffrey JeromeChief Commercial Officer
GrantCommon Stock 47,841 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-003459 · rdgdoc.xml · nonDerivative · entry 1

Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,792

F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Grantee's continued service with the Company through the applicable vesting date.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 23:58 UTC
NOUGUES MAXIMO FChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 85,067 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001437749-25-003461 · rdgdoc.xml · derivative · entry 2

NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,067

Underlying: Common Stock · 85,067 shares

Expires 2035-02-06

F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Optionee's continued service with the Company through the applicable vesting date.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 23:58 UTC
NOUGUES MAXIMO FChief Financial Officer
GrantCommon Stock 61,456 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-003461 · rdgdoc.xml · nonDerivative · entry 1

NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,751

F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Grantee's continued service with the Company through the applicable vesting date.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 23:53 UTC
HUNT DOUGLAS MSee Remarks
GrantStock Option (Right to Buy) · Derivative 66,604 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001437749-25-003456 · rdgdoc.xml · derivative · entry 2

HUNT DOUGLAS M · CIK 0001727172 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,604

Underlying: Common Stock · 66,604 shares

Expires 2035-02-06

F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Optionee's continued service with the Company through the applicable vesting date.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 23:53 UTC
HUNT DOUGLAS MSee Remarks
GrantCommon Stock 48,117 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-003456 · rdgdoc.xml · nonDerivative · entry 1

HUNT DOUGLAS M · CIK 0001727172 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,711

F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Grantee's continued service with the Company through the applicable vesting date.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 23:51 UTC
AUERBACH ALAN HDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 274,622 $0.00 Strike: $2.78 $0.00
Disclosure

SEC source: 0001437749-25-003454 · rdgdoc.xml · derivative · entry 2

AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,622

Underlying: Common Stock · 274,622 shares

Expires 2035-02-06

F2 · derivative.exercise_date: Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares (as defined in the Plan) subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to acceleration in certain events.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 23:51 UTC
AUERBACH ALAN HDirector · President and CEO · 10% owner
GrantCommon Stock 198,399 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-003454 · rdgdoc.xml · nonDerivative · entry 1

AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,228,073

F1 · shares: Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to acceleration in certain events.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 19:31 UTC
Ludwig Jeffrey JeromeChief Commercial Officer
SaleCommon Stock 9,437 $3.15 $29,742.59
Disclosure

SEC source: 0001437749-25-000363 · rdgdoc.xml · nonDerivative · entry 1

Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,951

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
January 02, 2025 Filed Jan 4, 2025 00:28 UTC
HUNT DOUGLAS MSee Remarks
SaleCommon Stock 8,633 $3.15 $27,208.63
Disclosure

SEC source: 0001437749-25-000361 · rdgdoc.xml · nonDerivative · entry 1

HUNT DOUGLAS M · CIK 0001727172 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,594

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
January 02, 2025 Filed Jan 4, 2025 00:33 UTC
NOUGUES MAXIMO FChief Financial Officer
SaleCommon Stock 10,227 $3.15 $32,232.44
Disclosure

SEC source: 0001437749-25-000365 · rdgdoc.xml · nonDerivative · entry 1

NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 152,295

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
January 02, 2025 Filed Jan 4, 2025 00:12 UTC
AUERBACH ALAN HDirector · President and CEO · 10% owner
SaleCommon Stock 33,841 $3.15 $106,656.68
Disclosure

SEC source: 0001437749-25-000359 · rdgdoc.xml · nonDerivative · entry 1

AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,029,674

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 12, 2024 Filed Aug 14, 2024 01:09 UTC SaleCommon Stock 23,358 $3.49 $81,465.70
Disclosure

SEC source: 0001437749-24-026536 · rdgdoc.xml · nonDerivative · entry 1

MILLER MICHAEL PATRICK · CIK 0001236514 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.4201 to $3.5501, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · balance_after: Corrects the amount that was erroneously reported as held in the Form 4 filed on June 21, 2024 with the Securities and Exchange Commission.

Read SEC document
July 17, 2024 Filed Jul 18, 2024 19:06 UTC
Ludwig Jeffrey JeromeChief Commercial Officer
SaleCommon Stock 2,598 $3.70 $9,615.46
Disclosure

SEC source: 0001437749-24-023020 · rdgdoc.xml · nonDerivative · entry 1

Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,388

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 17, 2024 Filed Jul 18, 2024 23:11 UTC
NOUGUES MAXIMO FChief Financial Officer
SaleCommon Stock 4,156 $3.70 $15,381.77
Disclosure

SEC source: 0001437749-24-023022 · rdgdoc.xml · nonDerivative · entry 1

NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 162,522

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 17, 2024 Filed Jul 18, 2024 22:57 UTC
HUNT DOUGLAS MSee Remarks
SaleCommon Stock 3,637 $3.70 $13,460.90
Disclosure

SEC source: 0001437749-24-023017 · rdgdoc.xml · nonDerivative · entry 1

HUNT DOUGLAS M · CIK 0001727172 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,227

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 17, 2024 Filed Jul 18, 2024 22:50 UTC
AUERBACH ALAN HDirector · President and CEO · 10% owner
SaleCommon Stock 21,920 $3.70 $81,128.11
Disclosure

SEC source: 0001437749-24-023014 · rdgdoc.xml · nonDerivative · entry 1

AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,063,515

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 02, 2024 Filed Jul 2, 2024 21:19 UTC
Ludwig Jeffrey JeromeChief Commercial Officer
SaleCommon Stock 6,051 $3.27 $19,777.69
Disclosure

SEC source: 0001437749-24-022065 · rdgdoc.xml · nonDerivative · entry 1

Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,986

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 02, 2024 Filed Jul 3, 2024 01:22 UTC
NOUGUES MAXIMO FChief Financial Officer
SaleCommon Stock 5,295 $3.27 $17,306.71
Disclosure

SEC source: 0001437749-24-022067 · rdgdoc.xml · nonDerivative · entry 1

NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 166,678

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 02, 2024 Filed Jul 3, 2024 01:15 UTC
HUNT DOUGLAS MSee Remarks
SaleCommon Stock 4,349 $3.27 $14,214.71
Disclosure

SEC source: 0001437749-24-022063 · rdgdoc.xml · nonDerivative · entry 1

HUNT DOUGLAS M · CIK 0001727172 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 136,864

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 02, 2024 Filed Jul 3, 2024 01:10 UTC
AUERBACH ALAN HDirector · President and CEO · 10% owner
SaleCommon Stock 18,885 $3.27 $61,725.62
Disclosure

SEC source: 0001437749-24-022061 · rdgdoc.xml · nonDerivative · entry 1

AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,085,435

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 18, 2024 Filed Jun 22, 2024 01:25 UTC GrantCommon Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-021022 · rdgdoc.xml · nonDerivative · entry 1

Stuglik Brian M · CIK 0001716328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,058

F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 18, 2024 Filed Jun 22, 2024 01:27 UTC GrantCommon Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-021024 · rdgdoc.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,350

F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 18, 2024 Filed Jun 22, 2024 01:22 UTC GrantCommon Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-021020 · rdgdoc.xml · nonDerivative · entry 1

Senderowicz Adrian · CIK 0001616230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,000

F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 18, 2024 Filed Jun 22, 2024 01:21 UTC GrantCommon Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-021018 · rdgdoc.xml · nonDerivative · entry 1

MILLER MICHAEL PATRICK · CIK 0001236514 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,358

F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 18, 2024 Filed Jun 22, 2024 01:19 UTC
MOYES JAY MDirector
GrantCommon Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-021016 · rdgdoc.xml · nonDerivative · entry 1

MOYES JAY M · CIK 0001191062 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,322

F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 18, 2024 Filed Jun 22, 2024 01:17 UTC GrantCommon Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-021014 · rdgdoc.xml · nonDerivative · entry 1

Dorval Allison · CIK 0001625110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 18, 2024 Filed Jun 22, 2024 01:16 UTC GrantCommon Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-021012 · rdgdoc.xml · nonDerivative · entry 1

Cesano Alessandra · CIK 0001827015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,000

F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 13, 2024 Filed Jun 17, 2024 23:25 UTC SaleCommon Stock 9,900 $3.39 $33,528.33
Disclosure

SEC source: 0001437749-24-020572 · rdgdoc.xml · nonDerivative · entry 1

Stuglik Brian M · CIK 0001716328 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,058

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-16-2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
June 13, 2024 Filed Jun 17, 2024 23:27 UTC SaleCommon Stock 27,000 $3.33 $89,901.90
Disclosure

SEC source: 0001437749-24-020574 · rdgdoc.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 350

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2801 to $3.5801, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
June 13, 2024 Filed Jun 17, 2024 23:23 UTC SaleCommon Stock 27,000 $3.33 $89,818.20
Disclosure

SEC source: 0001437749-24-020570 · rdgdoc.xml · nonDerivative · entry 1

Senderowicz Adrian · CIK 0001616230 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2801 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
June 13, 2024 Filed Jun 17, 2024 23:21 UTC
MOYES JAY MDirector
SaleCommon Stock 22,000 $3.34 $73,466.80
Disclosure

SEC source: 0001437749-24-020568 · rdgdoc.xml · nonDerivative · entry 1

MOYES JAY M · CIK 0001191062 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,322

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
June 13, 2024 Filed Jun 17, 2024 23:18 UTC SaleCommon Stock 11,000 $3.37 $37,096.40
Disclosure

SEC source: 0001437749-24-020566 · rdgdoc.xml · nonDerivative · entry 1

Dorval Allison · CIK 0001625110 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,000

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 03-06-2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 01:01 UTC
AUERBACH ALAN HDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 9,047 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001437749-24-008575 · rdgdoc.xml · derivative · entry 2

AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,047

Underlying: Common Stock · 9,047 shares

Expires 2034-03-14

F1 · shares: Reflects supplemental annual equity awards due to an administrative error in the calculations used to determine the original number of shares underlying the annual equity awards.

F3 · derivative.exercise_date: Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 01:01 UTC
AUERBACH ALAN HDirector · President and CEO · 10% owner
GrantCommon Stock 6,577 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-008575 · rdgdoc.xml · nonDerivative · entry 1

AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,104,320

F1 · shares: Reflects supplemental annual equity awards due to an administrative error in the calculations used to determine the original number of shares underlying the annual equity awards.

F2 · shares: Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 18:00 UTC
Ludwig Jeffrey JeromeChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 37,466 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001437749-24-004214 · rdgdoc.xml · derivative · entry 2

Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,466

Underlying: Common Stock · 37,466 shares

Expires 2034-02-11

F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 18:00 UTC
Ludwig Jeffrey JeromeChief Commercial Officer
GrantCommon Stock 27,067 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-004214 · rdgdoc.xml · nonDerivative · entry 1

Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,037

F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 23:03 UTC
Wong Alvin FChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 59,946 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001437749-24-004218 · rdgdoc.xml · derivative · entry 2

Wong Alvin F · CIK 0001868855 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,946

Underlying: Common Stock · 59,946 shares

Expires 2034-02-11

F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 23:03 UTC
Wong Alvin FChief Scientific Officer
GrantCommon Stock 43,307 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-004218 · rdgdoc.xml · nonDerivative · entry 1

Wong Alvin F · CIK 0001868855 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,241

F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 23:01 UTC
NOUGUES MAXIMO FChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 59,946 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001437749-24-004216 · rdgdoc.xml · derivative · entry 2

NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,946

Underlying: Common Stock · 59,946 shares

Expires 2034-02-11

F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 23:01 UTC
NOUGUES MAXIMO FChief Financial Officer
GrantCommon Stock 43,307 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-004216 · rdgdoc.xml · nonDerivative · entry 1

NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,973

F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 22:58 UTC
AUERBACH ALAN HDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 222,573 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001437749-24-004211 · rdgdoc.xml · derivative · entry 2

AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,573

Underlying: Common Stock · 222,573 shares

Expires 2034-02-11

F2 · derivative.exercise_date: Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares (as defined in the Plan) subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 22:58 UTC
AUERBACH ALAN HDirector · President and CEO · 10% owner
GrantCommon Stock 160,796 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-004211 · rdgdoc.xml · nonDerivative · entry 1

AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,097,743

F1 · shares: Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 22:54 UTC
HUNT DOUGLAS MSee Remarks
GrantStock Option (Right to Buy) · Derivative 52,452 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001437749-24-004207 · rdgdoc.xml · derivative · entry 2

HUNT DOUGLAS M · CIK 0001727172 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,452

Underlying: Common Stock · 52,452 shares

Expires 2034-02-11

F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 22:54 UTC
HUNT DOUGLAS MSee Remarks
GrantCommon Stock 37,894 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-004207 · rdgdoc.xml · nonDerivative · entry 1

HUNT DOUGLAS M · CIK 0001727172 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,213

F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 19:00 UTC
Ludwig Jeffrey JeromeChief Commercial Officer
SaleCommon Stock 12,956 $4.49 $58,119.32
Disclosure

SEC source: 0001437749-24-000773 · rdgdoc.xml · nonDerivative · entry 1

Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 99,970

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.3601 to $4.7101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 00:03 UTC
Wong Alvin FChief Scientific Officer
SaleCommon Stock 7,733 $4.49 $34,689.46
Disclosure

SEC source: 0001437749-24-000776 · rdgdoc.xml · nonDerivative · entry 1

Wong Alvin F · CIK 0001868855 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,214

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.3601 to $4.7101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 23:56 UTC
AUERBACH ALAN HDirector · President and CEO · 10% owner
SaleCommon Stock 41,396 $4.49 $185,698.32
Disclosure

SEC source: 0001437749-24-000770 · rdgdoc.xml · nonDerivative · entry 1

AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,936,947

F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.3601 to $4.7101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.